Effectiveness and Safety of Certolizumab Pegol in Axial Spondyloarthritis in a Real-World Setting in Greece: A Sub-Analysis of the Prospective Non-Interventional CIMAX Cohort Study

OBJECTIVES: We report the effectiveness and safety of certolizumab pegol (CZP) treatment in a real-world Greek axial spondyloarthritis (axSpA) population, including patients with radiographic (r-axSpA) and non-radiographic (nr-axSpA) disease. METHODS: We performed a sub-analysis of the Greek cohort...

Descripción completa

Detalles Bibliográficos
Autores principales: Katsifis, Gkikas, Theodoridou, Athina, Bounas, Andreas, Georgiou, Panagiotis, Sfikakis, Petros, Fragiadaki, Kalliopi, Dimitroulas, Theodoros, Mole, Evangelia, Bauer, Lars, Kumke, Thomas, Hoepken, Bengt
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Mediterranean Journal of Rheumatology (MJR) 2022
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9450185/
https://www.ncbi.nlm.nih.gov/pubmed/36127922
http://dx.doi.org/10.31138/mjr.33.1.162

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9450185/
https://www.ncbi.nlm.nih.gov/pubmed/36127922
http://dx.doi.org/10.31138/mjr.33.1.162

Ejemplares similares